Lipe & Dalton
- SEC CIK
- 0001570396
- Latest filing
- Jul 14, 2026
ADVM holding history
Adverum Biotechnologies, Inc. in every 13F filed by Lipe & Dalton, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADVM overviewAll 13F holders of ADVMFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −1,500−100.0% | Sold outConverted for a 1-for-10 split | Holders |
| Q4 2023 | 15,000 | $11.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 15,000 | $22.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 15,000 | $24.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 15,000 | $11.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 15,000 | $9.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 15,000 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 15,000 | $18.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 15,000 | $20.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 15,000 | $26.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 15,000 | $33.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 15,000 | $52.0K | <0.1% | +15,000 | New | Holders |